A Major Currency Event is Unfolding
Contributed Opinion
Ngaere-2 Well Beats Expectations, Tariki Gas Storage Offer Imminent
Research Report
High-Grade Breccia Discovery in Mexico may Point to a Larger Porphyry System
Contributed Technical Analyst Opinion
Defense Tech Firm Advances GPS-Denied Navigation Breakthrough in Ukraine
Biotech Company Uncovers Breakthrough Canine Arthritis Treatment
Tech Company Attracts Breakthrough Billion-Dollar Activist Investment
When the World's on Fire, We Buy
Contributed Opinion
Uranium Company Advances Major Supply Breakthrough via Largest Resource in US
Uranium Energy Corp. (UEC:NYSE AMERICAN) restarts Wyoming mine, pursues conversion facility, and scales U.S. production assets amid domestic uranium shortage.Contango ORE, Dolly Varden Complete 'Transformative' Merger
Contango ORE Inc (CTGO:NYSEA) and Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) successfully complete what one expert calls a transformative merger.Trumped!
Contributed Opinion
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market, and shares one copper stock on his list. Energy Co. Begins KW1X Production Testing in Namibia: Six Zones, 346 MMbbl Upside and a 349% Target Return
Research Report
Research Capital reaffirmed its rating and target on Reconnaissance Energy Africa Ltd. (RECO:TSXV; RECAF:OTCQX; 0XD:FSE) as production testing kicked off at the KW1X well in Namibia. Copper and Titanium Mineralization Observed Across Broad Intervals in First Phase of U.S. Drill Program
Green Bridge Metals Corp. (GRBM:CSE; GBMCF:OTC; J48:FWB) reported visual sulphide mineralization across three initial drill holes at its Titac project in Minnesota.Royalty Presents Another Hurdle for Barrick
Contributed Opinion
Global Analyst Adrian Day updates us on developments at a couple of companies on his list. High-Grade Gold Intercepts and Expanding Resource Potential Highlight Major Northern District Drill Campaign
B2Gold Corp. (BTG:NYSE; BTO:TSX; B2G:NSX) reported high-grade drill results and expanded resource potential from its 2025 Back River Gold District program.Biotech Price Target Raised on Strong FSHD and DM1 siRNA Data
Research Report
Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising Phase 1/2 data for siRNA candidates SRP-1001 in FSHD and SRP-1003 in DM1, citing superior muscle concentration and a clean safety profile versus rival programs from Novartis and Dyne Therapeutics. 
Streetwise Key Charts
